Literature DB >> 25122155

Water-soluble and cleavable quercetin-amino acid conjugates as safe modulators for P-glycoprotein-based multidrug resistance.

Mi Kyoung Kim1, Hyunah Choo, Youhoon Chong.   

Abstract

Quercetin-amino acid conjugates with alanine or glutamic acid moiety attached at 7-O and/or 3-O position of quercetin were prepared, and their multidrug resistance (MDR)-modulatory effects were evaluated. A quercetin-glutamic acid conjugate, 7-O-Glu-Q (3a), was as potent as verapamil in reversing MDR and sensitized MDR MES-SA/Dx5 cells to various anticancer drugs with EC50 values of 0.8-0.9 μM. Analysis on Rh-123 accumulation confirmed that 3a inhibits drug efflux by Pgp, and Pgp ATPase assay showed that 3a interacts with the drug-binding site of Pgp to stimulate its ATPase activity. Physicochemical analysis of 3a revealed that solubility, stability, and cellular uptake of quercetin were significantly improved by the glutamic acid promoiety, which eventually dissociates from 3a to produce quercetin and quercetin metabolites in intracellular milieu. Taken together, potent MDR-modulating activity along with intracellular conversion into the natural flavonoid quercetin warrants development of the quercetin-amino acid conjugates as safe MDR modulators.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25122155     DOI: 10.1021/jm500290c

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  9 in total

Review 1.  The complex relationship between multiple drug resistance and the tumor pH gradient: a review.

Authors:  Tomas Koltai
Journal:  Cancer Drug Resist       Date:  2022-04-03

Review 2.  P-glycoprotein inhibitors of natural origin as potential tumor chemo-sensitizers: A review.

Authors:  Hossam M Abdallah; Ahmed M Al-Abd; Riham Salah El-Dine; Ali M El-Halawany
Journal:  J Adv Res       Date:  2014-12-01       Impact factor: 10.479

3.  Quercetin and doxorubicin co-encapsulated biotin receptor-targeting nanoparticles for minimizing drug resistance in breast cancer.

Authors:  Li Lv; Chunxia Liu; Chuxiong Chen; Xiaoxia Yu; Guanghui Chen; Yonghui Shi; Fengchao Qin; Jiebin Ou; Kaifeng Qiu; Guocheng Li
Journal:  Oncotarget       Date:  2016-05-31

Review 4.  Research Progress in the Modification of Quercetin Leading to Anticancer Agents.

Authors:  Alessandro Massi; Olga Bortolini; Daniele Ragno; Tatiana Bernardi; Gianni Sacchetti; Massimo Tacchini; Carmela De Risi
Journal:  Molecules       Date:  2017-07-29       Impact factor: 4.411

5.  Dual-functional Brij-S20-modified nanocrystal formulation enhances the intestinal transport and oral bioavailability of berberine.

Authors:  Wei Xiong; Wei Sang; Ke Gang Linghu; Zhang Feng Zhong; Wai San Cheang; Juan Li; Yuan Jia Hu; Hua Yu; Yi Tao Wang
Journal:  Int J Nanomedicine       Date:  2018-06-28

Review 6.  Overcoming Multidrug Resistance: Flavonoid and Terpenoid Nitrogen-Containing Derivatives as ABC Transporter Modulators.

Authors:  Bruno M F Gonçalves; David S P Cardoso; Maria-José U Ferreira
Journal:  Molecules       Date:  2020-07-24       Impact factor: 4.411

7.  ATR-Chk1 signaling inhibition as a therapeutic strategy to enhance cisplatin chemosensitivity in urothelial bladder cancer.

Authors:  Ching-Chia Li; Juan-Cheng Yang; Mei-Chin Lu; Chia-Lin Lee; Chieh-Yu Peng; Wei-Yu Hsu; Yun-Hao Dai; Fang-Rong Chang; Da-Yong Zhang; Wen-Jeng Wu; Yang-Chang Wu
Journal:  Oncotarget       Date:  2016-01-12

Review 8.  Chiral Flavonoids as Antitumor Agents.

Authors:  Cláudia Pinto; Honorina Cidade; Madalena Pinto; Maria Elizabeth Tiritan
Journal:  Pharmaceuticals (Basel)       Date:  2021-12-05

9.  Quercetin facilitates cell death and chemosensitivity through RAGE/PI3K/AKT/mTOR axis in human pancreatic cancer cells.

Authors:  Chieh-Yu Lan; Sheng-Yi Chen; Chia-Wen Kuo; Chi-Cheng Lu; Gow-Chin Yen
Journal:  J Food Drug Anal       Date:  2019-08-21       Impact factor: 6.157

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.